SEC CIK 1235945

WIERENGA WENDALL D

Reported ownership across 3 companies, sourced from SEC Form 4 filings and updated daily.

Current Positions

CompanyShares OwnedAs Of
CRNXview stock →116,1462025-06-11
CYTKview stock →32,3452025-07-15
NBIXview stock →02003-09-01

Position History — CYTK

Reported shares owned immediately after each Form 4 transaction, over time.

014,94929,89944,8482020-042021-072022-072023-042023-122024-112025-042025-07

Recent Filings — CYTK

DateActivitySharesPriceOwned After
2025-07-15Grant / award164$38.0132,345
2025-05-14Grant / award (derivative)10,880$0.0010,880
2025-05-14Grant / award7,333$0.0032,181
2025-04-21Option exercise (derivative)20,000$0.000
2025-04-21Option exercise20,000$6.2144,848
2025-04-21Open-market sale20,000$38.4624,848
2025-04-15Grant / award162$38.5624,848
2025-01-02Grant / award127$48.9324,686
2024-12-16Option exercise (derivative)742$0.000
2024-12-16Option exercise742$7.3725,301
2024-12-16Open-market sale742$48.6124,559
2024-11-25Option exercise (derivative)742$0.00742
2024-11-25Open-market sale742$50.0024,559
2024-11-25Option exercise742$7.3725,301
2024-10-28Option exercise (derivative)4,452$0.001,484
2024-10-28Open-market sale4,452$52.2524,559
2024-10-28Option exercise4,452$7.3729,011
2024-10-01Grant / award118$52.6024,559
2024-07-01Grant / award114$0.0024,441
2024-05-15Grant / award (derivative)3,636$0.003,636
2024-05-15Grant / award5,600$0.0024,327
2024-01-02Grant / award74$84.1218,727
2023-12-27Option exercise (derivative)5,000$0.005,000
2023-12-27Option exercise (derivative)5,000$0.000
2023-12-27Option exercise5,000$4.4423,653
2023-12-27Open-market sale5,000$73.6018,653
2023-10-02Grant / award448$27.8818,653
2023-08-21Option exercise (derivative)6,020$0.000
2023-08-21Option exercise6,020$6.7224,225
2023-08-21Open-market sale6,020$32.0218,205
2023-07-03Grant / award374$33.3618,205
2023-05-10Grant / award (derivative)10,000$0.0010,000
2023-05-10Grant / award5,000$0.0017,831
2023-04-03Grant / award298$37.7112,831
2023-02-06Option exercise (derivative)7,000$0.006,020
2023-02-06Open-market sale7,000$45.0012,533
2023-02-06Option exercise7,000$6.7219,533
2023-01-03Grant / award253$44.3512,533
2022-10-03Grant / award110$51.1112,280
2022-09-01Option exercise (derivative)4,166$0.000
2022-09-01Option exercise4,166$6.7816,336
2022-09-01Open-market sale4,166$52.7912,170
2022-07-01Grant / award137$41.0012,170
2022-05-10Grant / award (derivative)10,000$0.0010,000
2022-05-10Grant / award5,000$0.0012,033
2022-04-01Grant / award146$38.387,033
2022-01-03Grant / award122$46.006,887
2021-12-27Option exercise (derivative)4,166$0.000
2021-12-27Open-market sale4,166$44.376,765
2021-12-27Option exercise4,166$5.4610,931
2021-10-01Grant / award306$36.746,765
2021-07-07Grant / award63$19.776,459
2021-07-01Grant / award476$20.986,396
2021-05-12Grant / award (derivative)10,000$0.0010,000
2021-05-12Grant / award5,000$0.005,920
2021-04-01Grant / award409$24.44920
2021-01-04Grant / award511$19.56511
2020-05-13Grant / award (derivative)20,000$21.6120,000
2020-04-28Option exercise (derivative)6,666$16.000
2020-04-28Option exercise3,333$8.643,333
2020-04-28Open-market sale3,333$16.000
2020-04-28Option exercise6,666$11.046,666
2019-05-15Grant / award (derivative)20,000$10.6820,000
2018-05-16Grant / award (derivative)20,000$9.4520,000
2018-01-02Grant / award (derivative)5,714$3.505,714
2017-05-18Grant / award (derivative)20,000$0.0020,000
2017-01-03Grant / award (derivative)4,032$4.964,032
2016-05-18Grant / award (derivative)20,000$0.0020,000
2016-01-04Grant / award (derivative)4,375$4.004,375
2015-05-20Grant / award (derivative)20,000$0.0020,000
2015-01-02Grant / award (derivative)5,936$2.955,936
2014-05-21Grant / award (derivative)10,000$0.0010,000
2014-01-02Grant / award (derivative)13,020$2.6913,020
2013-05-22Grant / award (derivative)25,000$0.0025,000
2012-05-22Grant / award (derivative)25,000$0.0025,000
2011-05-18Grant / award (derivative)20,000$0.0020,000
2011-02-09Grant / award (derivative)40,000$0.0040,000

Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.